Circulating levels of galectin-9 are a potential biomarker of survival in advanced non-small-cell lung cancer.

Autor: Filho GVM; Translational Research Laboratory, Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil.; Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo City, São Paulo, Brazil., Costa GJ; Translational Research Laboratory, Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil.; Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo City, São Paulo, Brazil., Martins MR; Translational Research Laboratory, Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil.; Research Clinical Department, Hospital de Câncer de Pernambuco (HCP), Recife, Brazil., Torres LC; Translational Research Laboratory, Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil.; Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo City, São Paulo, Brazil.; Research Clinical Department, Hospital de Câncer de Pernambuco (HCP), Recife, Brazil.

Publikováno v: Journal of surgical oncology [J Surg Oncol] 2024 Sep; Vol. 130 (4), pp. 913-918. Date of Electronic Publication: 2024 Jul 24.